Status:
NOT_YET_RECRUITING
Effectiveness of Thyme in the Management of Clinical Symptoms in Patients with Irritable Bowel Syndrome
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Conditions:
Irritable Bowel Syndrome (IBS)
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn if thyme supplement enhances the effects of a low FODAMP diet on reducing clinical symptoms and improving the quality of life of patients with irritable bow...
Eligibility Criteria
Inclusion
- Ages 18-65;
- Patients with irritable bowel syndrome;
- Body Mass Index in the range of 18-25 kg/m2
Exclusion
- Any organic intestinal disease;
- Medical history of chronic gastrointestinal and colorectal disease;
- Any major bowel surgery;
- Medical history of liver and kidney disorders;
- Regular use of laxative, anti-diarrhea and anti inflammatory medications.
Key Trial Info
Start Date :
October 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2025
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT06609746
Start Date
October 21 2024
End Date
April 1 2025
Last Update
September 24 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.